Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding ...
Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding ...
Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...
Pilatus Biosciences, a biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the Company will present new preclinical ...
The Cyber Cell of the Crime Branch successfully executed a targeted operation, resulting in the arrest of 12 cybercriminals and the dismantling of well-organised cyber scam syndicates operating across ...
PALO ALTO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Excellergy, a biotechnology company developing a new class of allergy therapeutics, today announced its launch with a $70 million Series A ...
Syracuse, N.Y. — Section III boys soccer standings by class (through Oct. 12). If a team record is missing a game, please encourage coaches to send missing box scores to [email protected].
-Redefining Allergy Treatment with New Class of Trifunctional ECRIs designed to deliver powerful efficacy, rapid relief and complete control of allergic responses by targeting the effector cell - ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator.
A Johns Hopkins All Children’s Hospital team found that “hot-wiring” the immune microenvironment in mouse tumors, by co-activating STING and LTβR, rapidly recruits T and B cells, builds in-tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback